alexa
Reach Us +44-1522-440391
Editor - Petr O Ilyinskii | Seleecta Biosciences | 19325
ISSN: 2576-3881

Journal of Cytokine Biology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Petr O Ilyinskii

Petr O Ilyinskii
Petr O Ilyinskii
Senior Staff Scientist
Selecta Biosciences
USA

Biography

A trained virologist and immunologist with over 25 years of experience in the academic research and biotechnology industry in the fields of vaccine development, infectious disease and oncology. During his work at Harvard Medical School he discovered structure-functional relationship linking a number of retroviral and polyomaviral genes and regulatory regions with the viral pathogenesis and tissue tropism. At Therion Biologics he have participated in the development of early-stage cancer immunotherapy approaches and in the development of the first generation of recombinant anti-HIV vaccines (both are currently in Phase I/II trials). He led antiviral and vaccine development programs in several biotech companies and is listed as an inventor in a number of US patents and patent applications. His present role at Selecta is to lead/participate in several vaccine and immunotherapeutic nanoparticle-based development programs related to infectious disease, oncology and drug addiction as a senior immunologist/vaccinologist.

Research Interest

Current research interests are immune therapeutics development for immunostimulatory and tolerance-inducing applications, vaccines against substance use, viral and parasitic disease, adjuvant testing, immune therapy of cancer.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top